Anna B. Glinskii

2.8k total citations · 1 hit paper
22 papers, 2.2k citations indexed

About

Anna B. Glinskii is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anna B. Glinskii has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Anna B. Glinskii's work include Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (5 papers) and RNA modifications and cancer (4 papers). Anna B. Glinskii is often cited by papers focused on Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (5 papers) and RNA modifications and cancer (4 papers). Anna B. Glinskii collaborates with scholars based in United States, Ireland and Türkiye. Anna B. Glinskii's co-authors include Gennadi V. Glinsky, Gennadi V. Glinsky, William L. Gerald, Andrew J. Stephenson, Robert M. Hoffman, Robert M. Hoffman, Xiaoming Li, Aaron D. Schimmer, John C. Reed and Clemencia Pinilla and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anna B. Glinskii

22 papers receiving 2.1k citations

Hit Papers

Microarray analysis identifies a death-from-cancer signat... 2005 2026 2012 2019 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
    2005 708 citations Gennadi V. Glinsky, Anna B. Glinskii et al. Journal of Clinical Investigation profile →

Peers

Anna B. Glinskii
Nila U. Parikh United States
Randall Schreck United States
Jonathan Welti United Kingdom
Teresa C. Dugger United States
Paul Meltzer United States
Tobias Zellweger Switzerland
Sidong Huang Canada
Therese M. Becker Australia
Douglas W. McMillin United States
Ray Somcio United States
Nila U. Parikh United States
Anna B. Glinskii
Citations per year, relative to Anna B. Glinskii Anna B. Glinskii (= 1×) peers Nila U. Parikh

Countries citing papers authored by Anna B. Glinskii

Since Specialization
Citations

This map shows the geographic impact of Anna B. Glinskii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna B. Glinskii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna B. Glinskii more than expected).

Fields of papers citing papers by Anna B. Glinskii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna B. Glinskii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna B. Glinskii. The network helps show where Anna B. Glinskii may publish in the future.

Co-authorship network of co-authors of Anna B. Glinskii

This figure shows the co-authorship network connecting the top 25 collaborators of Anna B. Glinskii. A scholar is included among the top collaborators of Anna B. Glinskii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna B. Glinskii. Anna B. Glinskii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jun, Denise G. Lanza, Ian Guest, et al.. (2012). Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model. Tumor Biology. 33(6). 1983–1996. 41 indexed citations
2.
3.
Glinskii, Anna B., Shuang Ma, Chang‐Uk Lim, et al.. (2011). Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders. Cell Cycle. 10(20). 3571–3597. 20 indexed citations
4.
Yalçın, Murat, Dyskin Ea, Dhruba J. Bharali, et al.. (2010). Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid. The Journal of Clinical Endocrinology & Metabolism. 95(4). 1972–1980. 89 indexed citations
5.
Glinsky, Vladislav V., Galina M. Kiriakova, Olga V. Glinskii, et al.. (2009). Synthetic Galectin-3 Inhibitor Increases Metastatic Cancer Cell Sensitivity to Taxol-Induced Apoptosis In Vitro and In Vivo. Neoplasia. 11(9). 901–909. 47 indexed citations
6.
7.
Glinskii, Anna B., Gennadi V. Glinsky, Hung‐Yun Lin, et al.. (2009). Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac). Cell Cycle. 8(21). 3562–3570. 89 indexed citations
8.
Glinskii, Anna B., et al.. (2006). Essential Role for Activation of the Polycomb Group (PcG) Protein Chromatin Silencing Pathway in Metastatic Prostate Cancer. Cell Cycle. 5(16). 1886–1901. 128 indexed citations
9.
Glinsky, Gennadi V., Anna B. Glinskii, Bruce A. Smith, et al.. (2005). Dual-Color-Coded Imaging of Viable Circulating Prostate Carcinoma Cells Reveals Genetic Exchange between Tumor Cells In Vivo, Contributing to Highly Metastatic Phenotypes. Cell Cycle. 5(2). 191–197. 38 indexed citations
10.
Glinsky, Gennadi V., et al.. (2005). Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. Journal of Clinical Investigation. 115(6). 1503–1521. 708 indexed citations breakdown →
11.
Gebauer, Gerhard, Anja Krones‐Herzig, Anna B. Glinskii, & Gennadi V. Glinsky. (2005). Identification of genes associated with tumor progression using microarrays.. PubMed. 25(3A). 1477–82. 4 indexed citations
12.
Schimmer, Aaron D., Anna B. Glinskii, Clemencia Pinilla, et al.. (2005). Increased Expression of Apoptosis Inhibitor Protein XIAP Contributes to Anoikis Resistance of Circulating Human Prostate Cancer Metastasis Precursor Cells. Cancer Research. 65(6). 2378–2386. 193 indexed citations
13.
Glinsky, Gennadi V., Anna B. Glinskii, Andrew J. Stephenson, Robert M. Hoffman, & William L. Gerald. (2004). Gene expression profiling predicts clinical outcome of prostate cancer. Journal of Clinical Investigation. 113(6). 913–923. 24 indexed citations
14.
Glinsky, Gennadi V., Anna B. Glinskii, Andrew J. Stephenson, Robert M. Hoffman, & William L. Gerald. (2004). Gene expression profiling predicts clinical outcome of prostate cancer. Journal of Clinical Investigation. 113(6). 913–923. 343 indexed citations
15.
Glinsky, Gennadi V., Takuya Higashiyama, & Anna B. Glinskii. (2004). Classification of Human Breast Cancer Using Gene Expression Profiling as a Component of the Survival Predictor Algorithm. Clinical Cancer Research. 10(7). 2272–2283. 56 indexed citations
16.
Glinsky, Gennadi V., Anja Krones‐Herzig, Anna B. Glinskii, & Gerhard Gebauer. (2003). Microarray analysis of xenograft‐derived cancer cell lines representing multiple experimental models of human prostate cancer. Molecular Carcinogenesis. 37(4). 209–221. 22 indexed citations
17.
18.
19.
Khaldoyanidi, Sophia K., Lyudmila Sikora, Anna B. Glinskii, et al.. (2003). MDA-MB-435 Human Breast Carcinoma Cell Homo- and Heterotypic Adhesion under Flow Conditions Is Mediated in Part by Thomsen-Friedenreich Antigen-Galectin-3 Interactions. Journal of Biological Chemistry. 278(6). 4127–4134. 177 indexed citations
20.
Glinskii, Anna B., Bruce A. Smith, Ping Jiang, et al.. (2003). Viable circulating metastatic cells produced in orthotopic but not ectopic prostate cancer models.. PubMed. 63(14). 4239–43. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nila U. Parikh Breakdown of academic impact, for papers by Randall Schreck Breakdown of academic impact, for papers by Jonathan Welti Breakdown of academic impact, for papers by Teresa C. Dugger Breakdown of academic impact, for papers by Paul Meltzer Breakdown of academic impact, for papers by Tobias Zellweger Breakdown of academic impact, for papers by Sidong Huang Breakdown of academic impact, for papers by Therese M. Becker Breakdown of academic impact, for papers by Douglas W. McMillin Breakdown of academic impact, for papers by Ray Somcio
Rankless by CCL
2026